WHO ICTRP trial
AN OPEN LABEL INTERNATIONAL MULTI-CENTER PHASE 2 ACTIVITY AND SAFETY STUDY OF…
EUCTR2005-000524-16-PT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-000524-16-PT |
|---|---|
| Public title | AN OPEN LABEL INTERNATIONAL MULTI-CENTER PHASE 2 ACTIVITY AND SAFETY STUDY OF SU011248 IN PATIENTS WITH ADVANCED / METASTATIC GASTRIC CANCER PROGRESSING OR RECURRING AFTER ONE PRIOR CHEMOTHERAPY |
| Scientific title | AN OPEN LABEL INTERNATIONAL MULTI-CENTER PHASE 2 ACTIVITY AND SAFETY STUDY OF SU011248 IN PATIENTS WITH ADVANCED / METASTATIC GASTRIC CANCER PROGRESSING OR RECURRING AFTER ONE PRIOR CHEMOTHERAPY |
| Primary sponsor | Laboratorios Pfizer, Lda |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Portugal;Italy |
| Conditions | Histologically or cytologically confirmed diagnosis of gastric adenocarcinoma or gastroesophageal junction adenocarcinoma (i.e. an adenocarcinoma with >50% extension in the stomach). Patients must present with stage IV disease not amenable… |
| Interventions | Product Code: SU011248 L-Malate Salt Pharmaceutical Form: Capsule, hard CAS Number: 341031-54-7 Current Sponsor code: SU011248 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 12,5- Product Code: SU011248… |
| Registration date | Nov 11, 2005 |
| Target size | 160 |
| Secondary IDs | A6181054 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: